BlackRock Inc. - ARBUTUS BIOPHARMA CORP ownership

ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 59 filers reported holding ARBUTUS BIOPHARMA CORP in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of ARBUTUS BIOPHARMA CORP
ValueSharesWeighting
Q3 2023$20,856,506
-9.0%
10,274,141
+3.1%
0.00%0.0%
Q2 2023$22,929,913
-10.6%
9,969,527
+17.8%
0.00%0.0%
Q1 2023$25,646,179
+26.5%
8,464,086
-2.7%
0.00%0.0%
Q4 2022$20,271,914
+42.1%
8,700,392
+16.5%
0.00%
Q3 2022$14,264,000
-30.2%
7,467,818
-1.0%
0.00%
-100.0%
Q2 2022$20,433,000
+0.5%
7,540,382
+10.5%
0.00%0.0%
Q1 2022$20,338,000
-15.2%
6,824,829
+10.7%
0.00%0.0%
Q4 2021$23,986,000
-5.8%
6,166,349
+3.9%
0.00%0.0%
Q3 2021$25,463,000
+44.0%
5,935,203
+1.7%
0.00%
Q2 2021$17,682,000
+153.1%
5,835,573
+178.2%
0.00%
Q1 2021$6,985,000
+8.0%
2,097,710
+15.2%
0.00%
Q4 2020$6,465,000
+97.5%
1,821,107
+74.2%
0.00%
Q3 2020$3,273,000
+739.2%
1,045,394
+387.9%
0.00%
Q2 2020$390,000
+271.4%
214,276
+106.7%
0.00%
Q1 2020$105,000
-61.7%
103,671
+5.2%
0.00%
Q4 2019$274,000
-73.1%
98,537
-85.3%
0.00%
Q3 2019$1,019,000
-25.6%
668,556
+1.6%
0.00%
Q2 2019$1,369,000
-83.5%
658,289
-71.5%
0.00%
Q1 2019$8,278,000
-10.9%
2,312,132
-4.6%
0.00%
Q4 2018$9,286,000
-59.4%
2,424,682
+0.1%
0.00%
-100.0%
Q3 2018$22,891,000
+31.1%
2,422,221
+1.3%
0.00%0.0%
Q2 2018$17,455,000
+405.9%
2,391,143
+246.6%
0.00%
Q1 2018$3,450,000
-9.1%
689,906
-8.2%
0.00%
Q4 2017$3,794,000
+6223.3%
751,314
+7615.3%
0.00%
Q3 2017$60,0009,7380.00%
Other shareholders
ARBUTUS BIOPHARMA CORP shareholders Q4 2019
NameSharesValueWeighting ↓
Two Seas Capital LP 825,569$3,211,0002.46%
GREAT POINT PARTNERS LLC 668,907$2,602,0000.58%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 270,000$1,050,0000.47%
QCM Cayman, Ltd. 10,205$40,0000.24%
Pitti Group Wealth Management, LLC 50,000$195,0000.22%
RTW INVESTMENTS, LP 2,504,493$9,742,0000.14%
Hudson Bay Capital Management LP 1,805,700$7,024,0000.07%
Quinn Opportunity Partners LLC 276,485$1,076,0000.07%
Kepos Capital LP 200,000$778,0000.06%
XTX Topco Ltd 29,026$113,0000.06%
View complete list of ARBUTUS BIOPHARMA CORP shareholders